![](/img/cover-not-exists.png)
Antibodies to Infliximab in Patients Treated with Either the Reference Biologic or the Biosimilar CT-P13 Show Identical Reactivity Towards Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease
Fiorino, Gionata, Ruiz-Argüello, Begoña, Maguregui, Ainara, Nagore, Daniel, Radice, Simona, Gilardi, Daniela, Correale, Carmen, Allocca, Mariangela, Furfaro, Federica, Alfieri, Marina F., Martínez, AnVolume:
152
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(17)31533-0
Date:
April, 2017
File:
PDF, 420 KB
english, 2017